These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 32816175)

  • 21. Optimization of virus yield as a strategy to improve rabies vaccine production by Vero cells in a bioreactor.
    Trabelsi K; Rourou S; Loukil H; Majoul S; Kallel H
    J Biotechnol; 2006 Jan; 121(2):261-71. PubMed ID: 16153733
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of small ruminant morbillivirus, rift valley fever virus and lumpy skin disease virus in CelCradle™ -500A bioreactors.
    Rhazi H; Safini N; Mikou K; Alhyane M; Tadlaoui KO; Lin X; Venkatesan NP; Elharrak M
    BMC Vet Res; 2021 Feb; 17(1):93. PubMed ID: 33639955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel process for production of hepatitis A virus in Vero cells grown on microcarriers in bioreactor.
    Sun MB; Jiang YJ; Li WD; Li PZ; Li GL; Jiang SD; Liao GY
    World J Gastroenterol; 2004 Sep; 10(17):2571-3. PubMed ID: 15300909
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of rabies virus produced in Vero cells grown in serum free medium.
    Trabelsi K; Ben Zakour M; Kallel H
    Vaccine; 2019 Nov; 37(47):7052-7060. PubMed ID: 31300287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of Newcastle disease virus by Vero cells grown on cytodex 1 microcarriers in a 2-litre stirred tank bioreactor.
    Arifin MA; Mel M; Abdul Karim MI; Ideris A
    J Biomed Biotechnol; 2010; 2010():586363. PubMed ID: 20625497
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Japanese encephalitis virus production in Vero cells with serum-free medium using a novel oscillating bioreactor.
    Toriniwa H; Komiya T
    Biologicals; 2007 Oct; 35(4):221-6. PubMed ID: 17400474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Application of Ambr15 system for simulation of entire SARS-CoV-2 vaccine production process involving macrocarriers.
    Jayson A; Goldvaser M; Dor E; Monash A; Levin L; Cherry L; Lupu E; Natan N; Girshengorn M; Epstein E; Rosen O
    Biotechnol Prog; 2022 Sep; 38(5):e3277. PubMed ID: 35633106
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wave microcarrier cultivation of MDCK cells for influenza virus production in serum containing and serum-free media.
    Genzel Y; Olmer RM; Schäfer B; Reichl U
    Vaccine; 2006 Aug; 24(35-36):6074-87. PubMed ID: 16781022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of microcarrier cell culture process for the inactivated enterovirus type 71 vaccine development.
    Wu SC; Liu CC; Lian WC
    Vaccine; 2004 Sep; 22(29-30):3858-64. PubMed ID: 15364432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Single-Use Fixed-Bed Bioreactors in Scalable Virus Production.
    Lesch HP; Valonen P; Karhinen M
    Biotechnol J; 2021 Jan; 16(1):e2000020. PubMed ID: 32971565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".
    Tapia F; Wohlfarth D; Sandig V; Jordan I; Genzel Y; Reichl U
    PLoS One; 2019; 14(11):e0224317. PubMed ID: 31689309
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of influenza H1N1 vaccine from MDCK cells using a novel disposable packed-bed bioreactor.
    Sun B; Yu X; Kong W; Sun S; Yang P; Zhu C; Zhang H; Wu Y; Chen Y; Shi Y; Zhang X; Jiang C
    Appl Microbiol Biotechnol; 2013 Feb; 97(3):1063-70. PubMed ID: 22945265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of packed bed bioreactor systems in the production of viral vaccines.
    Rajendran R; Lingala R; Vuppu SK; Bandi BO; Manickam E; Macherla SR; Dubois S; Havelange N; Maithal K
    AMB Express; 2014; 4():25. PubMed ID: 24949260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing enterovirus A71 vaccine production yield by microcarrier profusion bioreactor culture.
    Liu CC; Wu SC; Wu SR; Lin HY; Guo MS; Yung-Chih Hu A; Chow YH; Chiang JR; Shieh DB; Chong P
    Vaccine; 2018 May; 36(22):3134-3139. PubMed ID: 28274636
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.
    Petiot E; Proust A; Traversier A; Durous L; Dappozze F; Gras M; Guillard C; Balloul JM; Rosa-Calatrava M
    Vaccine; 2018 May; 36(22):3101-3111. PubMed ID: 28571695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of novel disposable bioreactors on pandemic influenza virus production.
    Lai CC; Weng TC; Tseng YF; Chiang JR; Lee MS; Hu AY
    PLoS One; 2019; 14(8):e0220803. PubMed ID: 31404117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture.
    Liu CC; Lian WC; Butler M; Wu SC
    Vaccine; 2007 Jan; 25(1):19-24. PubMed ID: 16919374
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-cell-density cultivations to increase MVA virus production.
    Vázquez-Ramírez D; Genzel Y; Jordan I; Sandig V; Reichl U
    Vaccine; 2018 May; 36(22):3124-3133. PubMed ID: 29433897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-pH Endocytic Entry of the Porcine Alphaherpesvirus Pseudorabies Virus.
    Miller JL; Weed DJ; Lee BH; Pritchard SM; Nicola AV
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30355685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.